{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:19:11Z","timestamp":1769044751071,"version":"3.49.0"},"reference-count":52,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5734-25","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:07:53Z","timestamp":1750874873000},"page":"278-284","source":"Crossref","is-referenced-by-count":1,"title":["Primary Dedifferentiated Liposarcoma of the Duodenum with Intestinal Bleeding: A Case Report and Literature Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Yuki","family":"Noguchi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Ohta General Hospital Foundation Ohta Nishinouchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemichi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ohta General Hospital Foundation Ohta Nishinouchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeaki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ohta General Hospital Foundation Ohta Nishinouchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ohta General Hospital Foundation Ohta Nishinouchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer 119: 2922-2930, 2006.","DOI":"10.1002\/ijc.22239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dei Tos AP. Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol 4: 252-266, 2000.","DOI":"10.1053\/adpa.2000.8133"},{"key":"3","unstructured":"3. The WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours, WHO Classification of Tumours. 5th ed. IARC Press, Lyon, 2020: 36-48."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lee ATJ, Thway K, Huang PH, Jones RL. Clinical and molecular spectrum of liposarcoma. J Clin Oncol 36: 151-159, 2018.","DOI":"10.1200\/JCO.2017.74.9598"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Whitham Z, Blackham A, Loven V. A case of primary duodenal liposarcoma. Case Rep Oncol 13: 649-654, 2020.","DOI":"10.1159\/000507479"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Atik M, Whittlesey RH. Liposarcoma of jejunum. Ann Surg 146: 837-482, 1957.","DOI":"10.1097\/00000658-195711000-00018"},{"key":"7","unstructured":"7. Mohandas D, Chandra RS, Srinivasan V, Bhaskar AG. Liposarcoma of the ileum with secondaries in the liver. Am J Gastroenterol 58: 172-176, 1972."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Papadopoulos T, Kirchner T, Bergmann M, M\u00fcller-Hermelink HK. Primary liposarcoma of the jejunum. Pathol Res Pract 186: 803-806; discussion 807-808, 1990.","DOI":"10.1016\/S0344-0338(11)80276-1"},{"key":"9","unstructured":"9. Rivkind AI, Admon D, Yarom R, Schreiber L. Myxoid liposarcoma of the small intestine mimicking acute appendicitis. Eur J Surg 160: 251-252, 1994."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vartanian RK, O&apos;Connell JX, Holden JK, et al. Primary jejunal well-differentiated liposarcoma (atypical lipomatous tumor) with leiomyosarcomatous dedifferentiation. Int J Surg Pathol 4: 29-36, 1996.","DOI":"10.1177\/106689699600400106"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Manipadam MT, Singh R, Vijay A. Dedifferentiated liposarcoma presenting as jejunal polyp. Case report. APMIS 115: 1450-1453, 2007.","DOI":"10.1111\/j.1600-0463.2007.00851.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Benaragama KS, Neequaye SK, Maudgil D, Gordon AG. Small bowel liposarcoma - a rare cause of small bowel perforation. BMJ Case Rep 2010: bcr1020092364, 2010.","DOI":"10.1136\/bcr.10.2009.2364"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Patel J, Deb R, Speake W, Macculloch TA. Primary small bowel liposarcoma (atypical lipomatous tumour) with myogenic differentiation. Sarcoma 2010: 807981, 2010.","DOI":"10.1155\/2010\/807981"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jeong D, Kim SW. Dedifferentiated subserosal liposarcoma of the jejunum: sonographic and computed tomographic findings with pathologic correlation. Clin Imaging 36: 390-393, 2012.","DOI":"10.1016\/j.clinimag.2011.10.015"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okabayashi T, Shima Y, Iwata J, et al. Primary liposarcoma of the duodenum: a first case presentation. Intern Med 52: 2753-2757, 2013.","DOI":"10.2169\/internalmedicine.52.1230"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nennstiel S, Mollenhauer M, Schlag C, et al. Small bowel pleomorphic liposarcoma: a rare cause of gastrointestinal bleeding. Case Rep Gastrointest Med 2014: 391871, 2014.","DOI":"10.1155\/2014\/391871"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matsuo K, Inoue M, Shirai Y, et al. A rare case of primary small bowel de-differentiated liposarcoma causing intussusception: A case report. Medicine (Baltimore) 97: e11069, 2018.","DOI":"10.1097\/MD.0000000000011069"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gajzer DC, Fletcher CD, Agaimy A, Brcic I, Khanlari M, Rosenberg AE. Primary gastrointestinal liposarcoma - a clinicopathological study of 8 cases of a rare entity. Hum Pathol 97: 80-93, 2020.","DOI":"10.1016\/j.humpath.2019.12.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kim NI, Lee JS, Choi C, et al. S. Primary duodenal dedifferentiated liposarcoma: a case report and literature review. World J Clin Cases 10: 2007-2014, 2022.","DOI":"10.12998\/wjcc.v10.i6.2007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rubio-Garc\u00eda JJ, Sevila Mic\u00f3 S, Villodre Tudela C, Ramia-\u00c1ngel JM. Primary duodenal liposarcoma, an exceedlingly rare small bowel tumour. ANZ J Surg 92: 2326-2327, 2022.","DOI":"10.1111\/ans.17440"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Warnick J, Lahiri R, Karanjia N, Fisher C, Bagwan I. Well differentiated liposarcoma presenting as a duodenal polyp: a case report and review of the literature. Int J Surg Pathol 31: 307-311, 2023.","DOI":"10.1177\/10668969221099628"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Alvi AT, Shankar M. Primary dedifferentiated duodenal liposarcoma with gastric outlet obstruction: a rare small bowel tumor. Cureus 15: e50978, 2023.","DOI":"10.7759\/cureus.50978"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sch\u00f6ffski P. Established and experimental systemic treatment options for advanced liposarcoma. Oncol Res Treat 45: 525-543, 2022.","DOI":"10.1159\/000524939"},{"key":"24","unstructured":"24. Gootee JM, Curtin CE, Aurit SJ, Randhawa SE, Kang BY, Silberstein PT. Treatment facility: an important prognostic factor for dedifferentiated liposarcoma survival. Fed Pract 36: S34-S41, 2019."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Crago AM, Socci ND, DeCarolis P, et al. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clin Cancer Res 18: 1334-1340, 2012.","DOI":"10.1158\/1078-0432.CCR-11-2820"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mussi C, Colombo P, Bertuzzi A, et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Indian J Surg Oncol 2: 320-326, 2011.","DOI":"10.1007\/s13193-011-0090-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21: 271-281, 1997.","DOI":"10.1097\/00000478-199703000-00002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Thway K. Well-differentiated liposarcoma and dedifferentiated liposarcoma: an updated review. Semin Diagn Pathol 36: 112-121, 2019.","DOI":"10.1053\/j.semdp.2019.02.006"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of &quot;dedifferentiation&quot; . Am J Surg Pathol 16: 1051-1058, 1992.","DOI":"10.1097\/00000478-199211000-00003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 21: 943-949, 2008.","DOI":"10.1038\/modpathol.2008.84"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chung L, Lau SK, Jiang Z, et al. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Am J Surg Pathol 33: 1594-1600, 2009.","DOI":"10.1097\/PAS.0b013e3181accb01"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sciot R. MDM2 amplified sarcomas: a literature review. Diagnostics (Basel) 11: 496, 2021.","DOI":"10.3390\/diagnostics11030496"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. AlBathi AK, Mashhor YM, Muharib AA, Altawili AA. Intraperitoneal liposarcoma: a case report and literature review of a rare entity. Cureus 16: e59244, 2024 28.","DOI":"10.7759\/cureus.59244"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nimura F, Nakasone T, Matsumoto H, et al. Dedifferentiated liposarcoma of the oral floor: a case study and literature review of 50 cases of head and neck neoplasm. Oncol Lett 15: 7681-7688, 2018.","DOI":"10.3892\/ol.2018.8274"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Davis EC, Ballo MT, Luna MA, et al. Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head Neck 31: 28-36, 2009.","DOI":"10.1002\/hed.20923"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Fujibuchi T, Imai H, Kidani T, Morino T, Miura H. Serum lactate dehydrogenase levels predict the prognosis of patients with soft tissue sarcoma. Mol Clin Oncol 16: 02498, 2022.","DOI":"10.3892\/mco.2022.2498"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wang X, Liu S, Zhao X, Fang E, Zhao X. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: a meta-analysis. PLoS One 14: e0219215, 2019.","DOI":"10.1371\/journal.pone.0219215"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Aggerholm-Pedersen N, Baad-Hansen T, M\u00f8ller HJ, Sandfeld-Paulsen B. Role of high-sensitivity C-reactive protein in patients with sarcoma. Oncol Lett 25: 189, 2023.","DOI":"10.3892\/ol.2023.14118"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nakamura T, Asanuma K, Hagi T, Sudo A. C-reactive protein and related predictors in soft tissue sarcoma (review). Mol Clin Oncol 20: 2704, 2024.","DOI":"10.3892\/mco.2023.2704"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Posch F, Panotopoulos J, Funovics PT, et al. Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma. J Orthop Res 34: 1417-1425, 2016.","DOI":"10.1002\/jor.23002"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Fang E, Wang X, Feng J, Zhao X. The prognostic role of Glasgow prognostic score and C-reactive protein to albumin ratio for sarcoma: a system review and meta-analysis. Dis Markers 2020: 8736509, 2020.","DOI":"10.1155\/2020\/8736509"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Bramwell VHC, Anderson D, Charette ML; Sarcoma Disease Site Group. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 2003: CD003293, 2003.","DOI":"10.1002\/14651858.CD003293"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Gahvari Z, Parkes A. Dedifferentiated liposarcoma: systemic therapy options. Curr Treat Options Oncol 21: 15, 2020.","DOI":"10.1007\/s11864-020-0705-7"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Nishio J, Nakayama S, Nabeshima K, Yamamoto T. Biology and management of dedifferentiated liposarcoma: state of the art and perspectives. J Clin Med 10: 3230, 2021.","DOI":"10.3390\/jcm10153230"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Zhou MY, Bui NQ, Charville GW, Ganjoo KN, Pan M. Treatment of de-differentiated liposarcoma in the era of immunotherapy. Int J Mol Sci 24: 9571, 2023.","DOI":"10.3390\/ijms24119571"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Nakamura H, Takada K, Emori M, Hayasaka N, Sugita S. Complete response to eribulin in a patient with unresectable liposarcoma: a case report and implications of new biomarkers. Intern Med 61: 3617-3621, 2022.","DOI":"10.2169\/internalmedicine.9423-22"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Mavroeidis L, Napolitano A, Huang P, Jones RL. Novel therapeutics in soft tissue sarcoma. Cancers (Basel) 17: 10, 2024.","DOI":"10.3390\/cancers17010010"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Mowery YM, Ballman KV, Hong AM, et al. SU2C-SARC032: a randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma. JCO 42: 11504, 2024.","DOI":"10.1200\/JCO.2024.42.16_suppl.11504"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Gootee J, Aurit S, Curtin C, Silberstein P. Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma. J Cancer Res Clin Oncol 145: 181-192, 2019.","DOI":"10.1007\/s00432-018-2777-3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Yee EJ, Stewart CL, Clay MR, McCarter MM. Lipoma and its doppelganger: the atypical lipomatous tumor\/well-differentiated liposarcoma. Surg Clin North Am 102: 637-656, 2022.","DOI":"10.1016\/j.suc.2022.04.006"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Horowitz J, Singhal M, Marrero D, et al. A Multi-modality treatment of retroperitoneal de-differentiated liposarcoma. Am J Case Rep 21: e919245, 2020.","DOI":"10.12659\/AJCR.919245"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Davis L, Zhu L, Mayo SC, et al. Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study. Res Sq [Preprint]. 2024.","DOI":"10.21203\/rs.3.rs-5397300\/v1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5734-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:34:24Z","timestamp":1768620864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5734-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5734-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5734-25"}}